TERADATA (DEL.) DL-,01/ US88076W1036 /
2024-06-02 7:03:41 PM | Chg. 0.000 | Volume | Bid7:03:41 PM | Ask7:03:41 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
29.600EUR | 0.00% | - Turnover: - |
29.600Bid Size: - | 30.400Ask Size: - | 2.91 bill.EUR | - | - |
GlobeNewswire
06-02
Allergic diseases directly cost between 1,800 and 6,600 euros per patient per year
GlobeNewswire
06-02
Merus Presents Interim Data on MCLA-145 Monotherapy and in Combination with Pembrolizumab at the 202...
GlobeNewswire
06-02
KFSHRC Successfully Treats Severe Case of "Xanthoma" After 26 Years of Suffering
GlobeNewswire
06-02
Seer Technology Access Center Provides Unprecedented Scale and Depth of Coverage for PrognomiQ’s Ear...
GlobeNewswire
06-02
Precede Biosciences Presents New Data at ASCO 2024 Demonstrating Accurate HER2 Status Detection Acro...
GlobeNewswire
06-02
ALX Oncology Presents First Evorpacept Combination Data with an Antibody-Drug Conjugate from Phase 1...
GlobeNewswire
06-02
Nanobiotix Announces New Data Showing Disease Control and Tumor Response in Patients Treated With RT...
GlobeNewswire
06-02
BIIB INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Biogen, Inc. Investors with Sub...
GlobeNewswire
06-02
Celldex Therapeutics Presents Data Demonstrating Profound Improvements in Angioedema in Barzolvolima...
GlobeNewswire
06-02
NVIDIA Enables Real-Time Healthcare, Industrial and Scientific AI Applications at the Edge With Ente...